Biodesix, Inc.BDSXNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+8.1%
5Y CAGR+15.2%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+8.1%/yr
vs +21.6%/yr prior
5Y CAGR
+15.2%/yr
Recent deceleration
Acceleration
-13.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
7 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$94.36M+4.6%
2024$90.25M+16.6%
2023$77.42M+3.7%
2022$74.64M+15.0%
2021$64.93M+39.7%
2020$46.49M+2.8%
2019$45.22M+32.7%
2018$34.09M-